New online COVID-19 mortality risk calculator could help determine who should get vaccines first

A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers who developed the calculator expect it to be useful to public health authorities for assessing mortality risks in different communities, and for prioritizing certain groups…

Financial distress negatively impacts well-being, satisfaction of breast cancer patients

CHICAGO (December 11, 2020): Financial toxicity among breast cancer patients is independently associated with worse psychological well-being following a mastectomy or lumpectomy operation. However, even small improvements in financial pressure associated with treatment-related costs can lead to better mental well-being and higher patient satisfaction with breast reconstruction, according to an “article in press” published on…

From publication bias to lost in information

The availability of clinical trial records has increased markedly in recent years. For instance, several documents from numerous sources are often available for a single clinical trial – sometimes with overlapping, but often incomplete information. Identifying and processing this information involves a great deal of resources and challenges. Using an example of information retrieval for…

Texas Biomed to test CBD/THC against HIV-induced neurological disorder

San Antonio, Texas (December 11, 2020) – The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND). This research project aims to evaluate whether delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)…